Agrigenomics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Agrigenomics Market Trends and Insights

Falling NGS Costs and Throughput Expansion

Rapid cost declines remain the most powerful accelerant for the agrigenomics market. Whole-genome sequencing has dropped from millions of dollars to roughly USD 500–600 per genome, allowing routine use in crop variety characterization and herd management.^{[1]Nature Editorial Team, “Genome sequencing costs keep tumbling,” nature.com} Illumina’s XLEAP-SBS chemistry boosts reads per flow cell, while Oxford Nanopore’s T2T assemblies yield gap-free genomes suited to complex trait mapping. BGI’s DNBSEQ-T7 raises daily throughput into the multi-terabase range and supports more than half of global sequencing projects. Capacity gains democratize access for mid-tier breeding programs that previously relied on outsourced genotyping, accelerating data generation and lowering per-sample turnaround time. As sequencing platforms bundle analytics and cloud pipelines, entry barriers continue to fall for cooperatives, universities, and small research stations.

Rising Demand for Climate-Resilient Seed and Livestock Lines

Escalating climate volatility places a premium value on drought, heat, and disease tolerance traits. USDA approval for HB4 drought-tolerant wheat underscores regulatory momentum toward resilient germplasm. India’s ICAR introduced genome-edited rice that yields 25% more under stress, illustrating adoption in markets highly exposed to weather risk. Corteva invested USD 25 million in Pairwise to exploit CRISPR editing for abiotic stress traits. The agrigenomics market leverages this priority as seed companies align Research and Development pipelines with climate adaptation, bundling genomics with remote phenotyping to shorten selection cycles.

Government Genomics Programs in Agri-Innovation Hubs

Public funding solidifies infrastructure and lowers private risk. The USDA’s AG2PI invests USD 220 million in shared data platforms and phenotyping facilities.^{[2]USDA Office of Communications, “USDA Announces AG2PI Initiative,” usda.gov} India’s 2024 Union Budget deploys digital public infrastructure for 60 million farmers and earmarks INR 750 crore (USD 89.6 million) for the AgriSURE startup fund. China’s 2024-2028 blueprint targets independent CRISPR toolkits for staple crops. The UK’s Precision Breeding Act accelerates commercialization paths for gene-edited cultivars. Coordinated public investment de-risks innovation for private breeders, stimulates startup ecosystems, and expands talent pipelines, collectively boosting agrigenomics market performance.

AI-Driven Predictive Breeding Platforms

Machine learning tightens the feedback loop between genotype and phenotype. Syngenta and InstaDeep train Large Language Models on genomic text to predict trait expression in corn and soybeans. Google spinout Heritable Agriculture applies deep learning to accelerate ideotype discovery across cereals. SEEDX raised USD 20 million to classify genetic purity from seed images, cutting lab assays from weeks to hours. Bayer partnered with Source.ag to merge greenhouse data with genomic selection, pushing faster vegetable product cycles. AI augments breeder intuition with probabilistic rankings that guide cross designs, reducing the cost and time required for field testing while raising success hit rates.

High Sequencing and Bioinformatics Capex

Even with falling variable costs, high upfront investment in sequencers, compute clusters, and talent slows uptake. Illumina’s NovaSeq X requires significant capital outlays alongside recurring reagent commitments. Smaller cooperatives struggle to recruit bioinformaticians, prompting interest in low-pass sequencing strategies that deliver acceptable accuracy at sequencing depths as low as 0.05-fold. Cloud-based “sequencing-as-a-service” mitigates infrastructure costs yet still leaves data-analysis knowledge gaps. Without dedicated grants or public-private consortia, many smallholders postpone genomics investment, constraining agrigenomics market penetration in regions where productivity gains would be highest.

Fragmented GMO and Gene-Edited Crop Regulations

Regulatory heterogeneity drives compliance costs and slows transnational deployment. The European Court of Justice ruled that gene-edited crops must follow GMO directives, maintaining a multi-year approval path. In contrast, Argentina exempts edits with no foreign DNA, and Brazil’s RN16 classifies edits case-by-case. A December 2024 U.S. District Court decision vacated parts of USDA’s revised biotech rule, injecting temporary uncertainty, although prior status reviews stand. For multinational breeders, parallel dossiers lengthen time-to-market and raise legal risks, dissuading smaller innovators and limiting cross-border data exchange.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Technology: NGS Gains Momentum Despite qPCR Dominance

Real-time PCR delivered 38.02% of 2025 revenue and remains the default for targeted assays, yet the segment’s share of the agrigenomics market is trending downward as breeders pursue richer variant catalogs. The agrigenomics market size tied to NGS platforms is projected to grow at a 12.22% CAGR, underpinned by investments in high-throughput sequencers, multiplexed barcoding, and single-tube library prep solutions. Constellation mapped-read workflows announced by Illumina promise structural-variant detection without traditional library construction. Oxford Nanopore’s ultra-long reads resolve telomere-to-telomere cereal genomes, aiding sub-QTL definition for drought resilience. Microarrays and capillary electrophoresis continue in germplasm banks for identity preservation, but their aggregate demand plateaus as full-genome data become cost-competitive.

NGS adoption accelerates because it couples readily with AI pipelines that demand dense variant matrices. Multi-omics add-ons—proteomics via Olink, methylomes via nanopore direct reading—convert raw sequences into functional insights. Instruments marketed as “pay-per-flowcell” reduce cash burn for mid-volume labs, while reagent rental deals lower barriers for emerging programs. As a result, “sequencing first” becomes standard in new crop improvement programs, and service providers report backlog spillovers into 2026, reinforcing the agrigenomics market’s shift from low-plex assays to comprehensive omics profiling.

By Application: Livestock Genomics Accelerates Despite Crop Dominance

Crops supplied 63.85% of revenue in 2025, reflecting decades of genomic selection in maize, soybean, and wheat. Still, livestock revenues are climbing at an 11.14% CAGR as producers capture measurable returns from genomic estimated breeding values. The agrigenomics market size for livestock is set to expand sharply once low-pass sequencing and imputation replace array-based genotyping across dairy, swine, and poultry herds. Approved PRRS-resistant pigs illustrate commercial value and regulatory feasibility in food animals.

Low-coverage WGS achieves perfect traceability sensitivity at just 5% genomic depth, making comprehensive variant discovery feasible for regional breeding centers. Long-read platforms uncover more than 10,000 structural variants in bovine genomes, enabling targeted edits that enhance feed efficiency without deleterious pleiotropy. Meanwhile, crop-focused pipelines integrate expression QTL and epigenomic marks to shorten selection cycles. Overall, livestock genomics is shifting from basic parentage testing to predictive selection for welfare, methane reduction, and disease elimination.

By Service Offering: Gene Expression Analysis Drives Innovation

Genotyping dominated 40.55% of 2025 revenues, yet gene-expression analysis is forecast at a 12.28% CAGR, becoming the fastest-growing value-add. Single-cell and spatial transcriptomics will unlock cell-type-specific networks underlying stress responses, guiding edits with higher precision. Illumina’s planned 2026 launch of spatial kits for non-model plants underscores industry commitment to multi-omic integration. Gene-expression data pairs with variant calls to build causal graphs that AI engines convert into actionable breeding targets, further expanding service-based demand in the agrigenomics market.

DNA fingerprinting and trait-purity testing remain regulatory staples, especially for seed-law compliance. Yet, clients increasingly purchase bundled packages that combine SNP calls, methylation states, and transcript abundance. Service providers pivot to subscription analytics, selling dashboards with continuous updates rather than single-point reports. As breeders grapple with data volume, vendors that package visualization, storage, and machine-learning inference gain stickiness, ensuring recurring revenue and deeper client engagement within the agrigenomics industry.

By Sequencer Type: Long-Read Technologies Challenge Illumina Leadership

Illumina HiSeq and NovaSeq platforms still accounted for 35.22% of the agrigenomics market share in 2025, benefiting from broad reagent ecosystems and established workflows. PacBio HiFi and Oxford Nanopore devices are slated for 13.15% CAGR, propelled by demand for telomere-to-telomere assemblies, pan-genomes, and phased haplotypes. Portable MinION units enable field labs to run disease diagnostics at stockades or farm gates, shortening feedback loops for veterinarians.

PacBio’s circular consensus reads yield Q30 accuracy on 20 kb segments, unraveling polyploid complexity in wheat and canola. Illumina’s response involves linked-read simplification and Azure-hosted data processing to keep lock-in high. Investors now price sequencing decisions on total-insight value versus cost-per-base, tilting procurement models toward platforms that reduce downstream assembly and annotation expenditure. As more national projects build reference pangenomes, long-read adoption will spread beyond flagship institutes to seed companies aiming for competitive advantage in structural-variant-rich traits.

Geography Analysis

North America controlled 41.68% of revenue in 2025, reflecting deep genomics infrastructure, large-scale federal funding, and a regulatory environment that largely aligns with technology deployment. The agrigenomics market benefits from integrated ecosystems connecting USDA labs, land-grant universities, and private breeders. The joint EPA-FDA-USDA framework drafted in 2024 clarified oversight boundaries and added transparency for developers, easing time-to-market. Meanwhile, voluntary carbon-credit protocols reward yield gains and methane reductions enabled by genomic interventions, creating secondary revenue channels.

Asia-Pacific represents the strongest growth engine at an 11.33% CAGR, supported by aggressive national roadmaps in China, India, and Australia. China’s 2024-2028 biotech blueprint positions genome editing as a pillar for food security and aims to localize entire toolchains from CRISPR nucleases to high-throughput phenotyping. India’s AgriSURE fund and digital crop survey rollout across 400 districts will push remote phenotyping and seed-tracking infrastructure to smallholders, feeding richer datasets into breeding programs. BGI’s throughput surpasses 50% of global sequencing capacity, making Shenzhen a global hub for pan-genome consortia in rice, banana, and rapeseed. As regional regulators increasingly differentiate between edits and transgenes, approval pipelines compress, lowering market-entry friction.

Europe posts steady incremental gains despite the EU’s stringent GMO regime. National divergence widens the UK’s Precision Breeding Act, simplifies approval procedures, whereas continental Europe continues to treat edits as GMOs, prolonging commercialization. South America sees resilient uptake: Brazil’s Bioinputs Law fosters biotech integration, and Argentina’s early-stage exemption model accelerates product launches. Africa shows latent demand but contends with infrastructure deficits and a chronic bioinformatics talent gap. Multilateral donors and commercial seed firms are piloting cloud-based genomics hubs to bridge the divide, a development likely to pull new participants into the agrigenomics market over the long term.  

Regulatory Landscape

Agrigenomics is shaped by a patchwork of biotechnology, food, and environmental oversight that affects how genomic data, edited traits, and testing services move from laboratories into breeding and commercialization. In the European Union, Regulation (EU) 2026/1388 (approved in June 2026) established a dedicated framework for plants produced by certain new genomic techniques, using a classification-based oversight approach that separates NGT plants into distinct categories and compliance paths rather than routing all gene-edited outcomes through legacy GMO rules.

In the United States, USDA APHIS remains central to biotechnology product oversight, but the regulatory environment has been transitional following a federal district court decision in December 2024 that vacated parts of the 2020 SECURE rule. USDA APHIS subsequently issued a conforming final rule (effective June 16, 2025) and continued stakeholder engagement in 2026, including discussions of an interim rule concept to restore regulatory efficiency, leaving developers and service providers managing documentation and review under revised interpretations while tracking updates across EPA-FDA-USDA roles.

Market Opportunities and Future Outlook

Clearer rules for gene-edited plants and national biotechnology policies are expanding practical use cases for agrigenomics services beyond discovery into deployment, creating room for providers that package compliant testing, traceability, and analytics. The EU advanced the NGT dossier as the Council adopted a position at first reading in April 2026, and Regulation (EU) 2026/1388 followed in June 2026, which is lifting demand for laboratories that can support variety characterization, identity preservation, and category-specific documentation across seed markets that operate pan-regionally.

Public programs and sustainability-linked breeding targets are also pulling agrigenomics toward integrated genotype-to-phenotype pipelines, favoring vendors that combine wet-lab throughput with bioinformatics and decision tools. USDA ARS National Program 301 (2023-2027) explicitly emphasizes integrating genomics, metabolomics, and phenomics for crop improvement, while Australia’s Zero Net Emissions Agriculture CRC is running a low-emissions grasses project with Barenbrug that uses gene editing and pasture breeding to reduce methane intensity. On the methods side, 2026 publications highlighting pangenome-based structural variant imputation in dairy cattle and genomic selection implementation strategies in public soybean breeding point to growing standardization of large-scale analytics workflows, supporting service models built around multi-omics, pangenomes, and repeatable selection pipelines rather than one-off genotyping.